Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

AVRF and UPEI collaboration awarded Innovation PEI Pilot and Discovery Fund grant

AVRF and UPEI collaboration awarded Innovation PEI Pilot and Discovery Fund grant

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

Fibroblasts help 'recruit' immune cells for tumor growth

Fibroblasts help 'recruit' immune cells for tumor growth

Research finds link between increased hygiene and higher rates of certain diseases in women

Research finds link between increased hygiene and higher rates of certain diseases in women

NuGEN expands NGS utility for microbial transcriptome analysis with Ovation Prokaryotic RNA-Seq System

NuGEN expands NGS utility for microbial transcriptome analysis with Ovation Prokaryotic RNA-Seq System

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

TU Delft receives EU grant to diagnose and monitor Crohn's disease using MRI scans

TU Delft receives EU grant to diagnose and monitor Crohn's disease using MRI scans

FDA approves Matrix's generic Protonix DR Tablets ANDA

FDA approves Matrix's generic Protonix DR Tablets ANDA

EU awards 3 million euros for improving assessment of MRI scans for Crohn’s disease

EU awards 3 million euros for improving assessment of MRI scans for Crohn’s disease

Furiex's MuDelta for diarrhea-predominant irritable bowel syndrome receives FDA Fast Track designation

Furiex's MuDelta for diarrhea-predominant irritable bowel syndrome receives FDA Fast Track designation

Mystery of 'inactive' defensin solved

Mystery of 'inactive' defensin solved

SQI fourth quarter net loss increases to $2,621,000

SQI fourth quarter net loss increases to $2,621,000

Repligen enters exclusive license agreement with UCI for use of HDAC3 inhibitors for memory disorders

Repligen enters exclusive license agreement with UCI for use of HDAC3 inhibitors for memory disorders

ACT Biotech releases telatinib Phase 2 trial data for metastatic stomach cancer

ACT Biotech releases telatinib Phase 2 trial data for metastatic stomach cancer

FDA accepts Vertex's telaprevir NDA for six-month Priority Review

FDA accepts Vertex's telaprevir NDA for six-month Priority Review

Message of health benefits of moderate drinking are hazardous and extremely dangerous

Message of health benefits of moderate drinking are hazardous and extremely dangerous

Baked goods made from hydrolyzed wheat flour are not toxic to celiac disease patients

Baked goods made from hydrolyzed wheat flour are not toxic to celiac disease patients

Autism Speaks Autism Treatment Network adds 17 sites in Canada and the U.S

Autism Speaks Autism Treatment Network adds 17 sites in Canada and the U.S

New findings show reduced vitamin D absorption in patients with quiescent CD

New findings show reduced vitamin D absorption in patients with quiescent CD

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.